3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
2
Recruiting
2
Completed
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Stomach Neoplasms
2
Gastroesophageal Reflux
1
Interventions
Oxaliplatin
81
S 1 (combination)
55
Capecitabine
44
apatinib
32
Paclitaxel
32
Docetaxel
32
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
pembrolizumab
9
Tegafur
9
Nivolumab
9
Neoadjuvant Therapy
9
Laparoscopy
8
Gastrectomy
8
Ramucirumab
7
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
tislelizumab
6
Gastroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Gastroenterostomy
×
Clear all
NCT02936193
2019-11-05
LAPPG
RenJi Hospital
Phase NA
Unknown
100 enrolled
NCT02572050
2016-04-20
AaRon
National Cancer Center, Korea
Phase 2
Unknown
87 enrolled